Evaluate Retention of an Orally Administered Device Using Gamma Scintigraphy
NCT ID: NCT00754091
Last Updated: 2019-03-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE1
16 participants
INTERVENTIONAL
2008-06-30
2008-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluate Retention of an Orally Administered Device Using Gamma Scintigraphy Study 2
NCT00780286
Evaluation of the Zynex Blood Volume Monitor in Healthy Adult Volunteers During a Blood Draw
NCT01834612
Clinical Evaluation of the Zynex Monitoring System, Model CM-1600
NCT05740644
Development of a Breath Test for Monitoring Patients With Liver Disease
NCT00244569
Feasibility Study of an Innovative Medical Device for Sampling the Contents of the Small Intestine.
NCT05477069
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Polymer based lubricating liquid
three sprays of radiolabeled polymer blend of carboxymethylcellulose, polyoxyl 40 stearate, and polyethylene oxide that coats and protects the mucus membrane
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Polymer based lubricating liquid
three sprays of radiolabeled polymer blend of carboxymethylcellulose, polyoxyl 40 stearate, and polyethylene oxide that coats and protects the mucus membrane
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Are able to tolerate the procedure and
* Be generally healthy
Exclusion Criteria
* Major diseases
* Taking medication regularly
* Radiation exposure recently
18 Years
40 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Procter and Gamble
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Walter J Doll, PhD, RPh
Role: PRINCIPAL_INVESTIGATOR
Scintipharma, Inc
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Walter J Doll, PhD, RPh
Lexington, Kentucky, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2008046
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.